Search

In Stock

Buy Oxbryta (voxelotor) Online

ISEASE INDICATIONS: Sickle Cell Disease

MANUFACTURER: Global Blood Therapeutics, Inc.

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Oxbryta, known by its generic name Voxelotor, is a pharmaceutical medication used to treat a rare genetic blood disorder called sickle cell disease (SCD).

$33,074.12

Clear
Compare

Oxbryta, known by its generic name Voxelotor, is a pharmaceutical medication used to treat a rare genetic blood disorder called sickle cell disease (SCD). Sickle cell disease is a hereditary condition characterized by the presence of abnormal hemoglobin in red blood cells, which can cause the cells to take on a characteristic “sickle” shape. These deformed blood cells can lead to a range of health problems, including pain, anemia, organ damage, and a decreased lifespan. Oxbryta is designed to help alleviate some of the complications associated with SCD. Here is a detailed description of Oxbryta (Voxelotor):

  1. Mechanism of Action: Voxelotor is classified as a hemoglobin oxygen affinity modulator. It works by increasing the affinity of hemoglobin for oxygen, thereby preventing the formation of the characteristic sickle-shaped red blood cells. By maintaining a more normal shape and flexibility, red blood cells are less likely to clump together and block blood vessels, which is a common problem in sickle cell disease.
  2. Indications: Oxbryta is indicated for the treatment of sickle cell disease (SCD) in adults and pediatric patients aged 12 years and older. It is specifically used to increase hemoglobin levels and reduce the frequency of vaso-occlusive crises, which are painful episodes caused by the blockage of blood vessels by sickled red blood cells.
  3. Administration: Voxelotor is available in tablet form and is typically taken orally once a day. The dosage may vary depending on the patient’s age, weight, and specific condition. Patients are advised to follow their healthcare provider’s instructions carefully.
  4. Effectiveness: Clinical studies have shown that Oxbryta can effectively increase hemoglobin levels and reduce the occurrence of vaso-occlusive crises in patients with sickle cell disease. It offers a novel approach to managing this condition and improving the quality of life for individuals affected by SCD.
  5. Safety Profile: Like all medications, Voxelotor may have potential side effects, including headache, diarrhea, abdominal pain, and rash. However, it is generally well-tolerated. Patients should discuss potential side effects and any concerns with their healthcare providers.
  6. Monitoring: Patients taking Oxbryta may require regular monitoring of their hemoglobin levels and overall response to treatment. This helps ensure that the medication is effectively managing their sickle cell disease.
  7. Contraindications: Voxelotor is generally not recommended for individuals with known hypersensitivity to the drug.
  8. Research and Development: Oxbryta represents a significant advancement in the treatment of sickle cell disease, a condition that has traditionally had limited treatment options. Ongoing research may explore its long-term safety and efficacy, as well as its potential use in younger patient populations.

It is important for individuals with sickle cell disease to consult with a healthcare provider who is knowledgeable about this condition and its treatment options. Oxbryta (Voxelotor) offers hope for improved symptom management and a better quality of life for those living with SCD.

Package

90 film-coated of 500 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Evrenzo (Roxadustat) Online

From $171.42
(0 Reviews)
DISEASE INDICATIONS: Anemia MANUFACTURER: Astellas Pharma Inc. FibroGen USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Pharmaceuticals and Medical Devices Agency (PMDA) Evrenzo, known by its generic name Roxadustat, is a pharmaceutical medication that belongs to a class of drugs called HIF-PH (Hypoxia-Inducible Factor Prolyl Hydroxylase) inhibitors. This innovative medication is primarily used to treat certain types of anemia, particularly those associated with chronic kidney disease (CKD) and inflammation.

Buy Givlaari (givosiran) Online

(0 Reviews)
DISEASE INDICATIONS: Acute Hepatic Porphyria (AHP) MANUFACTURER: Alnylam Pharmaceuticals USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Givlaari, known by its generic name Givosiran, is a pharmaceutical medication used to treat a rare genetic disorder called acute hepatic porphyria (AHP). This innovative medication represents a significant advancement in the management of this condition, which is characterized by recurrent, severe attacks of abdominal pain, neurological symptoms, and potential life-threatening complications.

Buy Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) Online

$24,063.64
(0 Reviews)
DISEASE INDICATIONS: Thromboembolism MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Andexxa, with its generic name coagulation factor Xa (recombinant), inactivated-zhzo, is a specialized medication used in the field of hematology and coagulation medicine. It is primarily designed to address life-threatening bleeding events or complications associated with the use of certain anticoagulant medications, specifically direct or indirect factor Xa inhibitors.

Buy Ondexxya (andexanet alfa) Online

$16,421.35
(0 Reviews)
DISEASE INDICATIONS: Thromboembolism MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Ondexxya, known by its generic name Andexanet Alfa, is a medication used as a reversal agent for certain anticoagulant medications. It is primarily used in emergency situations when rapid reversal of the anticoagulant effects is necessary, particularly in cases of life-threatening bleeding or when invasive procedures are required.

Buy Accrufer (ferric maltol) Online

(0 Reviews)
DISEASE INDICATIONS: Iron deficiency MANUFACTURER: Shield Therapeutics USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Swissmedic (CH) Accrufer, with the generic name ferric maltol, is a prescription medication used in the treatment of iron deficiency anemia in adults. It is classified as an iron replacement therapy and is designed to help raise and maintain healthy levels of iron in the body.

Buy Feraccru (ferric maltol) Online

$162.85
(0 Reviews)
DISEASE INDICATIONS: Iron deficiency MANUFACTURER: Shield Therapeutics USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Swissmedic (CH) Feraccru, known by its generic name Ferric Maltol, is a pharmaceutical medication used to treat iron deficiency anemia in adult patients with inflammatory bowel disease (IBD). It is a novel oral iron replacement therapy designed to help replenish iron levels in individuals who have difficulty absorbing iron through their gastrointestinal system.

Buy Adakveo (crizanlizumab) Online

$1,844.95
(0 Reviews)
DISEASE INDICATIONS: Sickle Cell Disease MANUFACTURER: Novartis USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Adakveo, with its active ingredient crizanlizumab, is a prescription medication used in the treatment of a specific medical condition known as sickle cell disease (SCD).

Back to Top
Product has been added to your cart